Beam Therapeutics (BEAM) Price to Sales (2020 - 2026)
Beam Therapeutics' (BEAM) Price to Sales came in at 22.71 for Q2 2026, down 20.1% from 28.44 a year earlier but up 52.2% from the prior quarter.
Analysis
Beam Therapeutics (BEAM) Price to Sales (2020 - 2026) Analysis & Trends
For FY2025, Beam Therapeutics' Price to Sales stood at 20.18, down 38.2% from FY2024.
- In prior years, Beam Therapeutics' Price to Sales was 32.65 in FY2024 (+455.1%), 5.88 in FY2023 (-87.1%), 45.76 in FY2022 (-56.5%) and 105.12 in FY2021 (-99.9%).
- Quarterly Price to Sales has run from a low of 5.48 in Q2 2024 to a high of 7546.19 in Q3 2021 over five years.
- On a year-over-year basis, Price to Sales has declined in each of the last three quarters, with growth averaging 207.8% over the last eight quarters.
- The strongest year-over-year quarter for Price to Sales in the past five years was Q3 2025, with growth of 663.4%; the weakest was Q2 2022, with a decline of 100.0%.
- According to Business Quant data, Price to Sales for the three prior quarters was 14.93 (Q1 2026), 20.18 (Q4 2025) and 44.16 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.71 |
| Mar 31, 2026 | 14.93 |
| Dec 31, 2025 | 20.18 |
| Sep 30, 2025 | 44.16 |
| Jun 30, 2025 | 28.44 |
| Mar 31, 2025 | 30.89 |
| Dec 31, 2024 | 32.65 |
| Sep 30, 2024 | 5.79 |
| Jun 30, 2024 | 5.48 |
| Mar 31, 2024 | 7.53 |
| Dec 31, 2023 | 5.88 |
| Sep 30, 2023 | 23.41 |
| Jun 30, 2023 | 31.05 |
| Mar 31, 2023 | 29.72 |
| Dec 31, 2022 | 45.76 |
| Sep 30, 2022 | 36.50 |
| Jun 30, 2022 | 35.39 |
| Mar 31, 2022 | 66.32 |
| Dec 31, 2021 | 105.12 |
| Sep 30, 2021 | 7,546.19 |
API Access
Beam Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=BEAM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "BEAM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=BEAM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();